FDA Inspection 1005907 — Bushu Pharmaceuticals Ltd
The FDA completed an inspection of Bushu Pharmaceuticals Ltd on February 2, 2017 in Kodama-Gun. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 2, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Kodama-Gun (Japan)